The Georgian Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Georgian Health Digest.

Press releases published on October 28, 2026

Oct. 28, 2026

Daré Bioscience Addresses New National Focus on Women’s Health in Virtual Investor “What This Means” Discussion

Indeterminate GlobeNewswire

Oct. 28, 2026

Avaí Bio and Austrianova Announce Publication in Frontiers in Aging Journal Highlighting Novel Cell Encapsulation-Based Approach to Sustained Klotho Delivery

Indeterminate GlobeNewswire

Oct. 28, 2026

SELLAS Life Sciences Reaches 80th Event in Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia

Indeterminate GlobeNewswire

Oct. 28, 2026

Palisade Bio Announces First Patient Dosed in Global Phase 2b ASCENTRA-UC Study Evaluating Once-Daily Oral PALI-2108 for the Treatment of Ulcerative Colitis

Indeterminate GlobeNewswire

Oct. 28, 2026

Spectral AI Schedules 2026 Third Quarter Financial Results and Conference Call

Indeterminate GlobeNewswire

Oct. 28, 2026

Chloe Kim Is Changing the Conversation Around ADHD in Women with Qelbree® for ‘Ms. Represented’ Campaign

Indeterminate GlobeNewswire

Oct. 28, 2026

Tarsus Pharmaceuticals Appoints Neera Clase as Chief Commercial Officer

Indeterminate GlobeNewswire

Oct. 28, 2026

RenovoRx to Participate at the Canaccord Genuity MedTech Diagnostics and Digital Health & Services Forum

Indeterminate GlobeNewswire

Oct. 28, 2026

Propanc Biopharma Advances Clinical Development Preparation for PRP Phase 1b First-In-Human Study in Up to 50 Advanced Cancer Patients

Indeterminate GlobeNewswire

Oct. 28, 2026

60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine in Nonclinical Models of Alpha-Gal Syndrome

Indeterminate GlobeNewswire

Oct. 28, 2026

MaxCyte to Participate in Three Upcoming Investor Conferences

Indeterminate GlobeNewswire

Oct. 28, 2026

ProQR to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming Conferences

Indeterminate GlobeNewswire

Oct. 28, 2026

Neumarker Enter Collaboration to Advance Precision Medicine in Depression

Indeterminate GlobeNewswire

Oct. 28, 2026

Noom Study Finds Members Further Along in Its GLP-1Rx Program Report Higher “Flourishing” and “Quality of Life”

Indeterminate GlobeNewswire

Oct. 28, 2026

Annexon to Host Virtual Investor Event on November 3, 2026: Vonaprument for the Treatment of Geographic Atrophy - Highlighting Key Aspects of Phase 3 ARCHER II Trial

Indeterminate GlobeNewswire

Oct. 28, 2026

Sofwave to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire

Oct. 28, 2026

Curabotics Enters National Contract with Capstone Health Alliance, Bringing Robotics and Automation to Hundreds of Hospitals

Indeterminate GlobeNewswire

Oct. 28, 2026

Humacyte Strengthens Intellectual Property Portfolio with Issuance of New U.S. Patent Covering Symvess and Other Bioengineered Tissues

Indeterminate GlobeNewswire

Oct. 28, 2026

Newron Pharmaceuticals to Participate in November Investor Conferences

Indeterminate GlobeNewswire

Oct. 28, 2026

INmune Bio, Inc. Announces Pricing of $4.50 Million Registered Direct Offering and Concurrent Private Placement

Indeterminate GlobeNewswire